PDT ship sinking fast! When will they fire the Captain?

Discussion in 'Sun Pharma' started by anonymous, Nov 14, 2017 at 11:32 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    are you smokin' crack ?

    'Subdued sales in the US' is a verbatim from the release.

    October sales were 900,000 Euros, but that's one month.

    I do think Q1 and the jcode could be big though.

    Sell the price increase !!!
     

  2. anonymous

    anonymous Guest

    I saw a different release that stated "strong sales in first year of launch" The Jcode changes the game
     
  3. anonymous

    anonymous Guest

    "In addition to the assignment of the permanent J-code, CMS announced the revision of current procedural terminology (CPT) codes relating to PDT, of which codes 96567, 96573 and 96574 will be relevant for the treatment of actinic keratoses with PDT. New code 96574 provides the highest remuneration for PDT application since it includes a provision for the debridement of premalignant hyperkeratotic lesion(s). Ameluz® is the only PDT drug available in the U.S. that includes debridement in the label."
     
  4. anonymous

    anonymous Guest

    ouch.
     
  5. anonymous

    anonymous Guest

    Karma
     
  6. anonymous

    anonymous Guest

    Unfortunate, but true.

    I'm on the acne side of the business and today my spouse went to a new derm (not one of my customers for clinical reasons).

    In their discussion, she mentioned my working for Sun and even though he doesn't do PDT, he was very vocal about having heard from his colleagues how Sun has increased 'ALA' pricing so dramatically the past few years.

    It was awkward and embarrassing for my spouse - someone who is not even a customer is bad mouthing us.
     
  7. anonymous

    anonymous Guest

    Is it possible that debridement is in their labeling because it does not work as well and debridement is needed.

    Also, you do not need a debridement labeling to debride. Dermatologists can debride as needed and bill appropriately per code.
     
  8. anonymous

    anonymous Guest

    I need your help!

    Regarding the new codes:
    Is there henceforward any competitive advantage of Ameluz compared to Levulan?
    Is it possible to use the last code (96574) with Levulan?
    How do the new codes going to affect the docs?
    Are the new codes an incentive for switching to PDT?

    Thanks in advance, a Biofrontera shareholder!

    O.W.
     
  9. anonymous

    anonymous Guest

    None of that wil really matter.

    The bottom line is that our customers are so pissed off that they're going to hand our asses back to ourselves in Q1 with the new codes.

    People on this thread have put the pricing blame on RG, but really, who was Ron's boss during those 20% and 40% price hikes ?

    He's you're friendly neighborhood Customer Engagement Manager, currently hiding under the radar.

    Yup.
     
  10. anonymous

    anonymous Guest

    Really?!?
     
  11. anonymous

    anonymous Guest

    RG was the mastermind and then blamed everyone else. He has no balls. He talks bad about management all the time behind their backs but all the ideas come from him. He is a phony and con man.
     
  12. anonymous

    anonymous Guest

    The whole DUSA team is phony and made up of con people, up and down. You think there is anyone on earth who was born with the mission of selling sun lamps to dermatologists. Derms profess to stay out of the sun at all cost and wear sunscreen, unless the solar assault comes from their offices and is billable. The game is over. Cannot sell snow to Eskimos any more. Time for Biofrontera to run with the phony, con person scheme.
     
  13. anonymous

    anonymous Guest

    You get better AK results with a flashlight and baby oil. Levulen is nothing more than an expensive cosmetic peel. Better off just using alpha hydroxys at a high concentration with an esthetician and save money.
     
  14. anonymous

    anonymous Guest

    yeah, you go ahead with the flashlight approach and in a few years you'll be looking for a Mohs surgeon to remove then reconstruct your nose.
     
  15. anonymous

    anonymous Guest

    The OIG is not concerned with those guys.
    They're after the bigger fish ... CEO/Managing Director
     
  16. anonymous

    anonymous Guest

    PDT is a sinking ship as a therapy. Dermatologists are the cheapest MFs alive. They will use anything that brings them cash and not use anything that is marginal in profit. Once Levulen became a high priced product and surged in price each year, the out of pocket is high and the ROI is low. Be assured that derms, or the PAs that work for them will go where the money is. Too many choices out there to stick with this voodoo technique.
     
  17. anonymous

    anonymous Guest

    They will go after these piss ants first to make them turn against big boys but wont let them off the hook. They will give plea deals but still serve time or pay huge fines. Either way their life in pharma will be over.
     
  18. anonymous

    anonymous Guest

    Customers are running inventory down ahead of BF J-code!
    Not looking like they're as interested in our spread selling this year
     
  19. anonymous

    anonymous Guest

    Derms know that all PDT is a scam. Will go with the concept and medication that brings them back the most profit. Levulen costs about $1 per vial to produce and 20-40% price increases are way out of touch. Eventually out of business. Feed the greed.
     
  20. anonymous

    anonymous Guest

    I had a doctor tell me today not to come back because she has enough Levulan until Dec. 31 and then she is switching to 100% Ameluz. She said she has been looking forward to this day. She said it isn't me but she was sick of the greedy Indians.